For pharma teams that already know AI is inevitable.
Thetrainhasalreadyleftthestation.
The companies extracting real value from AI don't have bigger budgets. They have a concrete first step. We build that step — in 3 weeks.
No commitment. No sales deck. Just context and next steps.
WHAT WE HEAR EVERY DAY
Sound familiar?
“We already have an AI tool. But nobody uses it the same way, the outputs are inconsistent, and nobody trusts the results.”
Commercial Excellence · Marketing
“Our MSL spends 40% of their time preparing materials that could be generated in minutes. But we don't know how to do it safely and compliantly.”
Medical Affairs · Regulatory
“We have the data. What's missing is the layer that makes it actionable for decision-makers — without always depending on us.”
BI & Data · Strategy
If you recognized at least one of these scenarios, the diagnosis takes 20 minutes.
USE CASES IN PHARMA
We don't sell AI.
We solve specific problems.
Automatic synthesis of medical literature, MSL briefings, Q&A on internal guidelines.
Content approval workflows, automated reporting, data extraction from PDFs and CRFs.
Field material generation adapted to HCP profile, localization and regulatory adaptation.
Implementation with sensitive data, GDPR and pharmaceutical sector regulatory requirements.
Simple by design.
Fast by necessity.
We don't do 6-month consultancies. We do 3-week pilots with measurable results or we don't proceed.
RAPID DIAGNOSIS
— 2 to 3 daysWe map the 1-2 processes with the highest friction and error risk.
Output: opportunity report + impact estimate.
IMPLEMENTATION
— 7 to 10 daysWe automate priority workflows without disrupting operations.
Output: working solution in the field, tested by the team.
VALIDATION
— 5 to 7 daysWe fine-tune in the field and measure impact on real metrics.
Output: KPI dashboard + next steps recommendation.
KPIs: time saved · volume processed · response time
KUREUS PILOT PROGRAM · LIMITED SLOTS
3 pilots.
Real results.
Published on site.
Before promising scale, we prove impact. We want to close 3 cases this quarter and publish the first validated results. These are the slots.
Private clinic with intensive clinical documentation operation.
1 / 1 vaga
Pharmaceutical operation with Medical Affairs or MSL team.
1 / 1 vaga
Commercial or marketing team with automation needs.
1 / 1 vaga
No commitment. We evaluate together whether it makes sense to proceed.
FREE RESOURCE
Where are you losing
time right now?
A practical 12-page guide with the 8 pharma processes where AI generates immediate ROI — with real examples and prioritization criteria.
kureus
AI em Pharma: Os 8 Processos de ROI Imediato
What's inside:
- →Medical literature synthesis — the fastest case to implement
- →BI reporting automation — what doesn't need IT to do
- →MSL content generation — what is safe and what is not
- →Security checklist for sensitive data in pharma
- →Business case template to present to leadership
"We've seen what happens when pharma teams adopt AI without structure. And what happens when they adopt it with it."
kureus is a consultancy specialized in AI for organizations that deal with sensitive information and regulated processes.
We work with Medical Affairs, Commercial Excellence, BI and Marketing teams — in contexts where security and compliance are not optional.
We don't sell software. We build solutions that work in the field, with the right tools for the right context.
What sets us apart
SECTOR SPECIALIZATION
We don't do generic AI. We work with pharma, health, and industry teams — where data is sensitive and compliance is non-negotiable.
REAL SPEED
From diagnosis to operational impact in under 3 weeks. No months of consulting before seeing any results.
ROI BEFORE SCALE
We don't ask for platform investment. The pilot costs a fraction — and proves the case before any larger commitment.
Frequently Asked Questions
What pharma teams ask us.
With kureus, a production-ready AI workflow is deployed in 3 weeks. Week 1: discovery and workflow mapping. Week 2: multi-agent system build. Week 3: validation with real data and KPI measurement. Most pharma AI projects fail because they try to boil the ocean — we start with one high-impact process and prove ROI before scaling.
Yes. All kureus systems are GDPR-compliant by design. We offer on-premise deployment for sensitive patient data, meaning data never leaves your infrastructure. Our systems integrate with existing EHR, CTMS, and EDMS platforms through secure APIs. We follow EMA and INFARMED guidelines for data handling in pharmaceutical contexts.
ChatGPT and Copilot are general-purpose tools. They don't understand pharma regulatory requirements, can hallucinate clinical data, and have no audit trail. kureus builds multi-agent systems — specialized AI agents that work together, each handling a specific part of the workflow (e.g., one agent retrieves literature, another validates against SOPs, a third generates the output). Every output is traceable, compliant, and validated against your internal guidelines.
Pilot programs start at €990/month for 3 AI workflows. The typical ROI we target: 60–80% reduction in manual processing time for Medical Information queries, 40% faster regulatory document preparation, and 3x more HCP interactions per MSL per week. We measure KPIs from day one — time saved, volume processed, response time — so the business case is clear before you scale.
Based on our analysis, the 3 highest-ROI departments are: (1) Medical Information — where AI can handle 70% of routine HCP queries automatically, freeing MSLs for strategic engagement. (2) Regulatory Affairs — where document cross-referencing, variation tracking, and submission preparation consume 50%+ of team time. (3) Pharmacovigilance — where adverse event case processing is highly structured and ideal for AI-assisted automation. Sales and Marketing follow closely, especially for content localization and HCP profiling.
We're based in Portugal and have deep expertise in Portuguese regulatory reality (INFARMED, SNS integration). However, our systems are built for European pharma compliance broadly — GDPR, EMA guidelines, and EU regulatory frameworks. We work with pharma companies operating in Portugal and across the EU.
Let's see if it makes sense
A 20-minute conversation is enough to understand if we have a solution for your context.